Immunoglobulin Nursing Society Holds First National Conference
- By BSTQ Staff
The Immunoglobulin Nursing Society (IgNS) held its first national conference in Orlando, Fla., August 3 through 5. The conference is a new educational initiative to develop and sustain the advancement of knowledge, education and practice of nursing in the field of immunoglobulin (IG) therapy. It featured in-depth educational sessions, hands-on practical workshops, industry-sponsored symposia and an exhibit hall featuring the top IG-related companies in the country.
Educational sessions included the latest developments in the field of IG therapy, including clinical indications, administration and adverse event prevention and management, updates on the IG clinical trial landscape and the role of nurse study coordinators, as well as an update on issues with IG reimbursement and patient advocacy. Several smaller group practical workshops were taught by leading IG nurse experts focusing on best practices in intravenous IG (IVIG) and subcutaneous IG (SCIG) administration.
“The IgNS National Conference represents a major shift in the current education and training of IG nurses who treat patients with chronic and life-threatening disorders,” said Jane Kirmse, RN, MSN, APRN-BC, president of IgNS. “The National Conference will provide nurses with an exceptional educational program to expand their knowledge, advance their skills and experience professional growth.”
